A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands

NCT00657774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: FlutiForm 250/10 ug
DRUG: FlutiForm 100/10 ug
DRUG: Oral Prednisone 10mg
DRUG: Placebo

Sponsor

SkyePharma AG

Collaborators

[object Object]